ResMed Price Prediction and Hype Density Breakdown

RMD -- USA Stock  

USD 102.98  2.05  1.95%

We analyze noise-free headlines and recent hype associated with ResMed which may create opportunities for some arbitrage if properly timed. With ResMed hype-based prediction module you can estimate the value of ResMed from the prospective of ResMed response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on ResMed over a specific investment horizon. Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

ResMed After-Hype Price Density Analysis

 Next price density 
 
Expected price to next headline

ResMed Estimiated After-Hype Price Volatility

October 19, 2018
102.98
Current Value
102.99
After-hype Price
Target Odds
  
107.73
Upside
ResMed is not too risky asset. Analysis and calculation of next after-hype price of ResMed is based on 1 month time horizon.

ResMed Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.36% 1.58% 0.01%  0.42% 6 Events / Month4 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
102.98102.990.01%
7,900% 

ResMed Hype Timeline

On 19 of October ResMed is traded for 102.98. This company has historical hype elasticity of 0.01 and average elasticity to hype of competition of -0.42. ResMed is estimated to increase in value after the next headline with price going to jump to 102.99. The average volatility of media hype impact on the company stock price is about 7900.0%. The price escalation on the next news is estimated to be 0.01% where as daily expected return is at this time at -0.36%. The volatility of related hype on ResMed is about 134.24% with expected price after next announcement by competition of 102.56. The company reported last year revenue of 2.34 B. Total Income to common stockholders was 315.59 M with profit before taxes, overhead, and interest of 1.36 B. Considering 30-days investment horizon, the next estimated press release will be in about 6 days.
Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections.

ResMed Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
DENTSPLY SIRONA(0.44) 5 per month 0.00 (0.0335)  2.17 (2.40)  6.29 
ResMed 0.02 6 per month 0.00 (0.18)  1.84 (2.61)  5.37 
Stryker Corporation(0.02) 6 per month 0.00 (0.0124)  1.42 (2.40)  5.76 
Teleflex Incorporated(6.90) 4 per month 0.00 (0.12)  2.32 (2.61)  5.34 
Varian Medical Systems(2.91) 3 per month 0.00 (0.0035)  2.05 (2.54)  5.09 
Agilent Technologies 0.07 5 per month 0.00 (0.18)  1.61 (2.22)  4.95 
IQVIA Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Cigna Corporation(1.89) 7 per month 1.29  0.25  1.94 (1.90)  4.53 
China Cord Blood Corporation 0.12 2 per month 2.39  0.09  3.90 (3.50)  12.54 
Equillium 0.18 3 per month 0.00  0.21  5.17 (1.64)  2,234 

Contributor Headline

Latest Prospective on ResMed

ResMed
  2 days ago at Macroaxis
Filed for Brett Sandercock
Hudson City exotic insider transaction detected
October 20, 2018 for Hermance Ronald E Jr
Ditech Holding exotic insider transaction detected
October 19, 2018 for First Pacific Advisors Lp
View All Premium Stories  

Investors are also interested in

Purchased over 100 shares
Active few hours ago
Purchased over 10K shares
Active few hours ago
Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Search macroaxis.com